In response to drug safety issues, India plans to seek a WHO assessment of its regulatory system. Core regulatory functions such as inspections, approvals, and enforcement will be assessed and benchmarked in the initiative. This move follows incidents of contaminated drugs causing child deaths.
WHO audit, India hopes, will restore shine to its ‘pharmacy of the world’ image
